Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Kerstin Berntorp

Kerstin Berntorp

Adjunct professor

Kerstin Berntorp

Continuous glucose monitoring in pregnant women with type 1 diabetes : an observational cohort study of 186 pregnancies

Author

  • Karl Kristensen
  • Linda E. Ögge
  • Verena Sengpiel
  • Karin Kjölhede
  • Annika Dotevall
  • Anders Elfvin
  • Filip K. Knop
  • Nana Wiberg
  • Anastasia Katsarou
  • Nael Shaat
  • Lars Kristensen
  • Kerstin Berntorp

Summary, in English

Aims/hypothesis: The aim of this study was to analyse patterns of continuous glucose monitoring (CGM) data for associations with large for gestational age (LGA) infants and an adverse neonatal composite outcome (NCO) in pregnancies in women with type 1 diabetes. Methods: This was an observational cohort study of 186 pregnant women with type 1 diabetes in Sweden. The interstitial glucose readings from 92 real-time (rt) CGM and 94 intermittently viewed (i) CGM devices were used to calculate mean glucose, SD, CV%, time spent in target range (3.5–7.8 mmol/l), mean amplitude of glucose excursions and also high and low blood glucose indices (HBGI and LBGI, respectively). Electronic records provided information on maternal demographics and neonatal outcomes. Associations between CGM indices and neonatal outcomes were analysed by stepwise logistic regression analysis adjusted for confounders. Results: The number of infants born LGA was similar in rtCGM and iCGM users (52% vs 53%). In the combined group, elevated mean glucose levels in the second and the third trimester were significantly associated with LGA (OR 1.53, 95% CI 1.12, 2.08, and OR 1.57, 95% CI 1.12, 2.19, respectively). Furthermore, a high percentage of time in target in the second and the third trimester was associated with lower risk of LGA (OR 0.96, 95% CI 0.94, 0.99 and OR 0.97, 95% CI 0.95, 1.00, respectively). The same associations were found for mean glucose and for time in target and the risk of NCO in all trimesters. SD was significantly associated with LGA in the second trimester and with NCO in the third trimester. Glucose patterns did not differ between rtCGM and iCGM users except that rtCGM users had lower LBGI and spent less time below target. Conclusions/interpretation: Higher mean glucose levels, higher SD and less time in target range were associated with increased risk of LGA and NCO. Despite the use of CGM throughout pregnancy, the day-to-day glucose control was not optimal and the incidence of LGA remained high.

Department/s

  • Obstetrics and Gynaecology (Lund)
  • Obstetric, Gynaecological and Prenatal Ultrasound Research
  • Diabetes and Celiac Unit
  • EXODIAB: Excellence in Diabetes Research in Sweden
  • Genomics, Diabetes and Endocrinology

Publishing year

2019-03-23

Language

English

Pages

1143-1153

Publication/Series

Diabetologia

Volume

62

Issue

7

Document type

Journal article

Publisher

Springer

Topic

  • Endocrinology and Diabetes
  • Obstetrics, Gynecology and Reproductive Medicine

Keywords

  • Continuous glucose monitoring
  • Fetal growth
  • Neonatal complications
  • Pregnancy
  • Type 1 diabetes

Status

Published

Research group

  • Obstetric, Gynaecological and Prenatal Ultrasound Research
  • Diabetes and Celiac Unit
  • Genomics, Diabetes and Endocrinology

ISBN/ISSN/Other

  • ISSN: 0012-186X